Cargando…
TRP14 promotes resistance to cisplatin by inducing autophagy in ovarian cancer
Cisplatin is a common chemotherapeutic agent against ovarian cancer; however, drug resistance is a major limiting factor for its use in clinical treatment. The underlying mechanisms of cisplatin resistance in ovarian cancer have not yet been fully elucidated. Thus, this study aimed to elucidate some...
Autores principales: | Tan, Wen-Xi, Xu, Tian-Min, Zhou, Zi-Long, Lv, Xue-Jiao, Liu, Jian, Zhang, Wen-Jing, Cui, Man-Hua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6718101/ https://www.ncbi.nlm.nih.gov/pubmed/31524236 http://dx.doi.org/10.3892/or.2019.7258 |
Ejemplares similares
-
Down-regulation of OGT promotes cisplatin resistance by inducing autophagy in ovarian cancer
por: Zhou, Fuxing, et al.
Publicado: (2018) -
FGF19 promotes cell autophagy and cisplatin chemoresistance by activating MAPK signaling in ovarian cancer
por: Zhu, Wei, et al.
Publicado: (2023) -
Fn14 overcomes cisplatin resistance of high-grade serous ovarian cancer by promoting Mdm2-mediated p53-R248Q ubiquitination and degradation
por: Wu, An-Yue, et al.
Publicado: (2019) -
Prenylation of dimeric cyclo-l-Trp-l-Trp by the promiscuous cyclo-l-Trp-l-Ala prenyltransferase EchPT1
por: Li, Wen, et al.
Publicado: (2023) -
YAP induces cisplatin resistance through activation of autophagy in human ovarian carcinoma cells
por: Xiao, Lan, et al.
Publicado: (2016)